Circulating tumour cells and hypercoagulability: a lethal relationship in metastatic breast cancer

被引：0
|
作者：
C. C. Kirwan
T. Descamps
J. Castle
机构：
[1] University of Manchester,Division of Cancer Sciences, Faculty of Biology, Medicine and Health, School of Medical Sciences, Manchester Cancer Research Centre
[2] Manchester University NHS Foundation Trust,Wythenshawe Hospital
[3] Manchester Academic Health Science Centre,Centre for Cancer Biomarker Sciences, Cancer Research UK Manchester Institute
[4] University of Manchester,undefined
来源：
Clinical and Translational Oncology | 2020年 / 22卷
关键词：
Coagulation; CTC; TAT; Fibrinogen; -Dimer; Survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：870 / 877
页数：7
相关论文
共 50 条
  • [31] Circulating tumour cells are associated with increased risk of venous thromboembolism in metastatic breast cancer patients
    Mego, M.
    De Giorgi, U.
    Broglio, K.
    Dawood, S.
    Valero, V.
    Andreopoulou, E.
    Handy, B.
    Reuben, J. M.
    Cristofanilli, M.
    BRITISH JOURNAL OF CANCER, 2009, 101 (11) : 1813 - 1816
  • [32] EXPRESSION OF CK-19 IN CIRCULATING TUMOUR CELLS FROM WOMEN WITH METASTATIC BREAST CANCER
    Soltani, S.
    Mokarian, F.
    Panjehpour, M.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : E8 - E8
  • [33] Circulating tumour cells in peripheral and central venous blood of patients with metastatic breast cancer.
    Peeters, Dieter
    Van den Eynden, Gert
    Benoy, Ina
    Trinh, Xuan Bich
    Van der Auwera, Ilse
    Van Laere, Steven
    van Dam, Peter
    Pauwels, Patrick
    Vermeulen, Peter
    Peeters, Marc
    Dirix, Luc
    ACTA CLINICA BELGICA, 2010, 65 (06): : 453 - 453
  • [34] Circulating tumour cells are associated with increased risk of venous thromboembolism in metastatic breast cancer patients
    M Mego
    U De Giorgi
    K Broglio
    S Dawood
    V Valero
    E Andreopoulou
    B Handy
    J M Reuben
    M Cristofanilli
    British Journal of Cancer, 2009, 101 : 1813 - 1816
  • [35] Genomic Analysis of Circulating Tumour Cells for Guiding Treatment Decisions in Patients with Metastatic Breast Cancer
    Allsopp, R.
    Page, K.
    Achaempong, E.
    Wren, E.
    Nteliopoulos, G.
    Wadsley, M.
    Coombes, R.
    Shaw, J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2023, 25 (11): : S106 - S106
  • [36] Impact of circulating tumour cells on survival of eribulin-treated patients with metastatic breast cancer
    Mayuko Ito
    Yoshiya Horimoto
    Emi Tokuda
    Fumi Murakami
    Toshitaka Uomori
    Takanori Himuro
    Katsuya Nakai
    Gotaro Orihata
    Kotaro Iijima
    Mitsue Saito
    Medical Oncology, 2019, 36
  • [37] Circulating tumour cells in breast cancer: Prognostic indicators, metastatic intermediates, or irrelevant bystanders? (Review)
    Hogan, Brian V.
    Peter, Mark B.
    Shenoy, Hrishikesh
    Horgan, Kieran
    Hughes, Thomas A.
    MOLECULAR MEDICINE REPORTS, 2008, 1 (06) : 775 - 779
  • [38] A comparative study of two detection platforms of circulating tumour cells in patients with metastatic breast cancer
    Peeters, Dieter
    Buys, Andy
    Ledegen, Hannah
    Moehlig, Kathlyn
    Oeyen, Steffi
    Rondas, Dieter
    De Beukelaer, Alexia
    Van Laere, Steven
    Vervoort, Liesbet
    Vermeulen, Peter
    Ung, Christopher
    Kockx, Mark
    Dirix, Luc
    CANCER RESEARCH, 2020, 80 (04)
  • [39] The significance of circulating tumour cells in breast cancer: A review
    Castle, J.
    Shaker, H.
    Morris, K.
    Tugwood, J. D.
    Kirwan, C. C.
    BREAST, 2014, 23 (05): : 552 - 560
  • [40] Circulating tumour cells in early breast cancer Reply
    Lucci, Anthony
    Hall, Carolyn
    LANCET ONCOLOGY, 2012, 13 (09): : E371 - E371
12345